(Q73280969)
Statements
Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors (English)
S Culine
C Théodore
M Bekradda
F Farhat
M J Terrier-Lacombe